Celldex Therapeutics reported $902K in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agenus AGEN:US $ 41M 6.46M
Amgen AMGN:US $ 1256M 147M
Applied Genetic Technologies AGTC:US $ 2.91M 0.65M
Aptinyx Inc APTX:US $ 2.11M 354K
Biocept BIOC:US $ 8.08M 0.83M
Bristol Myers Squibb BMY:US $ 2882M 62M
Celldex Therapeutics CLDX:US $ 0.9M 0.12M
Cytrx CYTR:US 1.63M 156.74K
Merrimack Pharmaceuticals MACK:US $ 84K 93K
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Newlink Genetics NLNK:US 854K 945K
Rigel Pharmaceuticals RIGL:US $ 2.15M 2.46M
Seattle Genetics SGEN:US $ 128.87M 41.64M